D.E. Shaw & Co’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-23,161
Closed -$42K 5523
2022
Q1
$42K Sell
23,161
-3,892
-14% -$12.1K ﹤0.01% 5182
2021
Q4
$129K Buy
+27,053
New +$109K ﹤0.01% 5005
2020
Q3
Sell
-26,317
Closed -$121K 3979
2020
Q2
$121K Buy
+26,317
New +$171K ﹤0.01% 3864
2019
Q3
Sell
-84,863
Closed -$268K 3903
2019
Q2
$268K Buy
84,863
+15,962
+23% +$505K ﹤0.01% 3357
2019
Q1
$2.6M Buy
68,901
+53,353
+343% +$1.99M ﹤0.01% 1978
2018
Q4
$565K Sell
15,548
-7,362
-32% -$227K ﹤0.01% 3029
2018
Q3
$786K Sell
22,910
-2,750
-11% -$88.7K ﹤0.01% 2832
2018
Q2
$828K Buy
+25,660
New +$886K ﹤0.01% 2817

Other funds holding IFRX

D.E. Shaw & Co's IFRX Position: Q2 2022 in Review

D.E. Shaw & Co sold out of InflaRx (IFRX) in Q2 2022, closing a stake of 23,161 shares — an estimated $42K sold.

D.E. Shaw & Co first reported a position in IFRX in Q2 2018 and held it in 8 quarters. The position peaked at $2.6M in Q1 2019. 27 funds tracked by Wall St. Rank hold IFRX as of Q2 2022.

  • D.E. Shaw & Co reported no remaining InflaRx position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 23,161 InflaRx shares in Q2 2022, an estimated $42K.
  • D.E. Shaw & Co first reported a position in InflaRx in Q2 2018 and held it in 8 quarters.
  • D.E. Shaw & Co's InflaRx position peaked at $2.6M in Q1 2019.
  • 27 funds tracked by Wall St. Rank held InflaRx as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.